New review highlights top strategies for smoking cessation

Bio­Marin is bring­ing promi­nent deal­mak­er James Sabry on­to its ex­ec­u­tive team, along with Am­gen rare dis­ease vet­er­an Greg Friberg. Sabry will start on Oct. 7

Pfiz­er has se­cured an FDA ap­proval for etrasi­mod in mod­er­ate to se­vere ul­cer­a­tive col­i­tis. It’s the sec­ond sphin­go­sine-1-phos­phate (S1P) drug to ar­rive on the UC